慢性淋巴细胞白血病

预约门诊

生存率

慢性淋巴细胞白血病患者的生存率各不相同。医务人员使用一种称为预后评分的方法来确定某些类型癌症的生存概率。慢性淋巴细胞白血病的预后评分范围为 0 到 10 分。评分越高，生存概率越低。评分取决于：

  • 年龄。
  • 所患癌症中是否存在某些基因改变。
  • 血液中一种具体蛋白质的含量。
  • 癌症的分期。

例如，对于评分为 0 到 1 分的慢性淋巴细胞白血病患者，五年生存率约为 90%。对于评分为 0 到 1 分的患者，10 年生存率约为 86%。随着评分升高，生存率会降低。对于评分为 7 到 10 分的慢性淋巴细胞白血病患者，生存至少五年的概率约为 23%。对于评分为 7 到 10 分的患者，10 年生存率为 0%。

请记住，生存率统计数据需要 5 年或 10 年才能收集完毕。最新的生存率数据包括五年多前接受慢性淋巴细胞白血病治疗的患者。这些患者可能没有接受过最新疗法。在过去数十年间，慢性淋巴细胞白血病的死亡率持续下降，生存率稳步提升。

申请预约
分期医生与科室
Dec. 31, 2025

Living with 慢性淋巴细胞白血病?

Connect with others like you for support and answers to your questions in the Blood Cancers & Disorders support group on Mayo Clinic Connect, a patient community.

Blood Cancers & Disorders Discussions

amyboylan1
Is there anything to help stop or slow progression of MGUS?

155 Replies Tue, Feb 03, 2026

sandramgus
Diagnosed: MGUS

149 Replies Tue, Feb 03, 2026

mjlandin
Does anyone else have MGUS?

1137 Replies Mon, Feb 02, 2026

See more discussions
  1. Niederhuber JE, et al., eds. Chronic lymphocytic leukemia. In: Abeloff's Clinical Oncology. 6th ed. Elsevier; 2020. https://www.clinicalkey.com. Accessed Sept. 8, 2025.
  2. Kaushansky K, et al., eds. Chronic lymphocytic leukemia. In: Williams Hematology. 10th ed. McGraw Hill; 2021. https://accessmedicine.mhmedical.com. Accessed Sept. 8, 2025.
  3. Stilgenbauer S. Overview of the complications of chronic lymphocytic leukemia. https://www.uptodate.com/contents/search. Accessed Sept. 8, 2025.
  4. Chronic lymphocytic leukemia/small lymphocytic leukemia. National Comprehensive Cancer Network. https://www.nccn.org/guidelines/guidelines-detail?category=1&id=1478. Accessed Sept. 8, 2025.
  5. Chronic lymphocytic leukemia treatment (PDQ) — Patient version. National Cancer Institute. https://www.cancer.gov/types/leukemia/patient/cll-treatment-pdq. Accessed Sept. 8, 2025.
  6. Chronic lymphocytic leukemia (CLL). Blood Cancer United. https://bloodcancerunited.org/blood-cancer/leukemia/chronic-lymphocytic-leukemia-cll. Accessed Sept. 8, 2025.
  7. Rosenthal DS, et al. Evaluation of the peripheral blood smear. https://www.uptodate.com/contents/search. Accessed Sept. 8, 2025.
  8. Targeted therapy to treat cancer. National Cancer Institute. https://www.cancer.gov/about-cancer/treatment/types/targeted-therapies. Accessed Sept. 8, 2025.
  9. Chemotherapy to treat cancer. National Cancer Institute. https://www.cancer.gov/about-cancer/treatment/types/chemotherapy#chemotherapy-can-cause-side-effects. Accessed Sept. 8, 2025.
  10. Immunotherapy side effects. National Cancer Institute. https://www.cancer.gov/about-cancer/treatment/types/immunotherapy/side-effects. Accessed Sept. 8, 2025.
  11. Radiation therapy side effects. National Cancer Institute. https://www.cancer.gov/about-cancer/treatment/types/radiation-therapy/side-effects. Accessed Sept. 8, 2025.
  12. Stem cell transplants in cancer treatments. National Cancer Institute. https://www.cancer.gov/about-cancer/treatment/types/stem-cell-transplant#stem-cell-transplant-side-effects. Accessed Sept. 8, 2025.
  13. T-cell transfer therapy. National Cancer Institute. https://www.cancer.gov/about-cancer/treatment/types/immunotherapy/t-cell-transfer-therapy. Accessed Sept. 8, 2025.
  14. Cancer-related fatigue. National Comprehensive Cancer Network. https://www.nccn.org/guidelines/guidelines-detail?category=3&id=1424. Accessed Sept. 8, 2025.
  15. Cancer stat facts: Leukemia — chronic lymphocytic leukemia (CLL). National Cancer Institute. https://seer.cancer.gov/statfacts/html/clyl.html. Accessed Sept. 8, 2025.
  16. Warner KJ. Allscripts EPSi. Mayo Clinic. Feb. 8, 2021.
  17. Shanafelt TD, et al. Hematologist/oncologist disease-specific expertise and survival: Lessons from chronic lymphocytic leukemia (CLL)/small lymphocytic leukemia (SLL). Cancer. 2012; doi:10.1002/cncr.26474.
  18. Ding W, et al. Pembrolizumab in patients with CLL and Richter transformation or with relapsed CLL. Blood. 2017; doi:10.1182/blood-2017-02-765685.
  19. Elsevier Point of Care. Clinical Overview: Febrile neutropenia in adults. https://www.clinicalkey.com. Accessed Sept. 8, 2025.
  20. Larson RA, et al. Tumor lysis syndrome: Prevention and treatment. https://www.uptodate.com/contents/search. Accessed Sept. 8, 2025.

相关

相关医疗程序

产品与服务

慢性淋巴细胞白血病